Assessment of SARS-CoV-2 Seropositivity During the First and Second Viral Waves in 2020 and 2021 Among Canadian Adults
2022; American Medical Association; Volume: 5; Issue: 2 Linguagem: Inglês
10.1001/jamanetworkopen.2021.46798
ISSN2574-3805
AutoresXuyang Tang, Abha Sharma, Maria Pasic, Patrick Brown, Karen Colwill, Hellen Gelband, H.C. Birnboim, Nico Nagelkerke, Isaac I. Bogoch, Aiyush Bansal, Leslie Newcombe, Justin Slater, Peter S. Rodriguez, Guowen Huang, Sze Hang Fu, Catherine Meh, Daphne Wu, Rupert Kaul, Marc‐André Langlois, Ed Morawski, Andy Hollander, Demetre Eliopoulos, Benjamin Aloi, Teresa Lam, Kento T. Abe, Bhavisha Rathod, Mahya Fazel‐Zarandi, Jenny Wang, Mariam Iskilova, Adrian Pasculescu, Lauren Caldwell, Miriam Barrios‐Rodiles, Zahraa Mohammed‐Ali, Nandita Vas, Divya Raman Santhanam, Eo Rin Cho, Kathleen Qu, Shreya Jha, Vedika Jha, Wilson Suraweera, Varsha Malhotra, Kathy Mastali, Richard Wen, Samir K. Sinha, Angus Reid, Anne‐Claude Gingras, Pranesh Chakraborty, Arthur S. Slutsky, Prabhat Jha,
Tópico(s)SARS-CoV-2 detection and testing
ResumoThe incidence of infection during SARS-CoV-2 viral waves, the factors associated with infection, and the durability of antibody responses to infection among Canadian adults remain undocumented.
Referência(s)